STAT Plus: Apotex to pay $24 million to settle price fixing charges stemming from long-running probe
APSTOCK
Apotex becomes the fourth company to settle criminal charges in a long-running federal government probe into price fixing among generic makers.
No hay comentarios:
Publicar un comentario